Real-World Management of Chronic Myelogenous Leukemia in an Underserved Patient Cohort at a Los Angeles Safety-Net Health System: Tyrosine Kinase Inhibitor Treatment Patterns and Outcomes From 2015 to 2024

By afschroeder • September 17, 2026

Zheng D, Nold T, Ramakrishnan N, Kim K, Tomassetti S. Real-World Management of Chronic Myelogenous Leukemia in an Underserved Patient Cohort at a Los Angeles Safety-Net Health System: Tyrosine Kinase Inhibitor Treatment Patterns and Outcomes From 2015 to 2024. Cancer Med. 2026 Sep;15(9):e72223. doi: 10.1002/cam4.72223. PMID: 42745440.

Tags: chronic myelogenous leukemia, county, Fellow, General Internal Medicine, Harbor UCLA, Hematology/Oncology, Hispanic, Publications, Resident, safety‐net, underserved

Beyond the field of view: Radiomics and artificial intelligence for organ-specific and systemic disease prediction from localized medical imaging

Wang L, Shi Y, Deng Z, Wang Y, Rigo De Righi D, Javed S, Qureshi TA, Yang JD, Xie Y, Pandol SJ, Li D. Beyond[...]

The Impact of Perioperative Immunosuppression on Post-surgical Outcomes in Patients with Inflammatory Bowel Disease

Valle NP, Roney AR, Noorian S, Greb AC, Weber AT, Sauk JS, Kwaan MR, Limketkai BN. The Impact of Perioperative Immunosuppression on Post-surgical Outcomes in[...]

Safety-Net FoodRx: Repeat Attendance and Produce Consumption Patterns in a Produce Distribution Program

Ferguson F, Baham M, McCarthy WJ, Brown AF, Casillas A, Vassar S, Moon G, Caldwell JI, Darwish-Elsherbiny F, Shah D, Kuo T. Safety-Net FoodRx: Repeat[...]